![]() ![]() ![]() This is life changing, game changing stuff IMO. I am no scientist but given that information its utterly compelling to me that if you can successfully identify the exact microbial genes that are missing or you can create change with a personalised live biotherapeutic product it is going to make a difference and clearly all evidence is pointing that way.ĤD are proving this with the data out in practically EVERY vertical they are working in. * There are between 10x and 100x more microbial genes in our body as there are human genes so in terms of genetic diversity of our body our microbial genes do more of the heavy lifting in the body than our own cells do. * There are as many Microbial cells in our body as human cells (Equal Parts) * There are circa 10 Trillion Microbes in our body In the video she explains how the microbiome differs from human to human and that: It just makes logical sense that this could well indeed be playing a major part in why some of us fall ill and others don’t. ![]() It's clear to me the link between the genetic make up of bacteria in the microbiome and both major diseases and lifestyle diseases. If you are invested here and have an hour to spare its well worth listening to what she has to say. * How recent breakthroughs are helping researchers decipher communication within bacteria and between the microbiome and human cells. * How the gut microbiome can be changed by fibers, antibiotics, and live bacterial therapies * How gut microbes can be measured at the strain level Bhatt of Stanford explains how the gut microbiome affects #cancer patients and recent breakthroughs to modify it might help cancer patients live better and longer Personalised Live Biotherapeutic Products (LBPs) medicine is the future IMOĪmi S. But forces are at play, which, for now, are preventing that from happening. I doubt you would be having any complaints about the science if this was trending upwards at >300p a share.which is about where it should be, for a start, imo. The issue is the share price manipulation. The preclinical work in neurodegen genuinely looks outstanding, with a trial to commence later this year. DP himself has stated that they are seeing a very good level of readacross from the preclinical work (in vivo), into the clinic, (in humans). You might as well ask who wants to fund an oil companies seismic and spudding activities, in order to get a barrel of oil. Lets hope another rabbit can be pulled out of the hat with regard to funding not by a placing, and the shorters can't get stock to close out.It sounds as if you want 4D to deliver a new modality of safe and effective drug without completing any 'science'. ( And even that depends on the big shorters closing their positions). It doesn't make as much sense to short a company with enough cash for 5 years +.Ī company with cash for 1 year though is a sitting duck, unless it can pull a fantastic rabbit out of the hat. UK companies are especially vulnerable as US ones seem mainly to raise much more capital. I've seen it many times on lots of different companies in the Oil and Biotec sectors. Sometimes, it looks like the shareprice is starting to rally, especially on the charts, only for lots of heavy sells to cancel things out at the end of the day. If they hammer the price daily, it can create a big drop. ![]() These shorts are betting/expecting a placing at a nice discount to be able to close out of their positions. It really is so easy for them to manipulate the share price downwards towards the end of the day, creating a very frustrating situation for investors. When a small loss-making company doesn't have much cash in the bank, it puts itself in a very exposed place with regards to professional shorters. Preying for a blue day - though judging how the share price performed in the US yesterday, it would seem unlikely. I'm as disappointed as anyone invested invested in DDDD - but I accept the ways of the world, I never predict where the share price is going and I deeply disapprove of those who regard ADVFN BBs as vehicles to influence others, to suit their own agendas - be they rampers or de-rampers. What should their moral response have been? When the efficacy of AZ and Pfizer Covid vaccines were proven and approved, other potential developers (such as SNG) were gutted - SNG shareholders took a beating. It amazes me that anyone (and this is not just Porky), think 'morals' should apply when investing "how dare anyone short a cancer research company" - good grief, does this really come as a shock? There we go again, more lengthy early morning repetition from Porky - although, missing is an acknowledgement of being wrong on Friday - and that, perhaps, share price forecasting is not in his gift. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |